Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Thériault R[au]:

Search results

Items: 1 to 50 of 281

1.

Self-Concept Clarity and the Bodily Self: Malleability Across Modalities.

Krol SA, Thériault R, Olson JA, Raz A, Bartz JA.

Pers Soc Psychol Bull. 2019 Oct 11:146167219879126. doi: 10.1177/0146167219879126. [Epub ahead of print]

PMID:
31603025
2.

Bone Metastasis of Breast Cancer.

Tahara RK, Brewer TM, Theriault RL, Ueno NT.

Adv Exp Med Biol. 2019;1152:105-129. doi: 10.1007/978-3-030-20301-6_7. Review.

PMID:
31456182
3.

Patterns of bronchial challenge testing in Canada.

Thériault R, Raz A.

Can J Respir Ther. 2018 Summer;54(2). doi: 10.29390/cjrt-2018-006. Epub 2018 Aug 1.

4.

Hormonal regulation of circuit function: sex, systems and depression.

Thériault RK, Perreault ML.

Biol Sex Differ. 2019 Feb 28;10(1):12. doi: 10.1186/s13293-019-0226-x. Review.

5.

The role of neuronal nitric oxide synthase in cocaine place preference and mu opioid receptor expression in the nucleus accumbens.

Thériault RK, Leri F, Kalisch B.

Psychopharmacology (Berl). 2018 Sep;235(9):2675-2685. doi: 10.1007/s00213-018-4961-1. Epub 2018 Jul 10.

PMID:
29992335
6.

Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ.

Hassett MJ, Jiang W, Hughes ME, Edge S, Javid SH, Niland JC, Theriault R, Wong YN, Schrag D, Punglia RS.

J Natl Compr Canc Netw. 2018 Apr;16(4):387-394. doi: 10.6004/jnccn.2018.7003.

PMID:
29632058
7.

Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.

Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA.

Breast Cancer Res Treat. 2018 Feb;167(3):751-759. doi: 10.1007/s10549-017-4553-5. Epub 2017 Oct 28.

PMID:
29079937
8.

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.

Van Poznak C, Somerfield MR, Barlow WE, Biermann JS, Bosserman LD, Clemons MJ, Dhesy-Thind SK, Dillmon MS, Eisen A, Frank ES, Jagsi R, Jimenez R, Theriault RL, Vandenberg TA, Yee GC, Moy B.

J Clin Oncol. 2017 Dec 10;35(35):3978-3986. doi: 10.1200/JCO.2017.75.4614. Epub 2017 Oct 16.

PMID:
29035643
9.

Magnetic Resonance Imaging of Trauma Patients Treated With Contemporary External Fixation Devices: A Multicenter Case Series.

Hayden BL, Theriault R, Bramlett K, Lucas R, McTague M, Bedi HS, Flacke S, Weaver MJ, Marcantonio AJ, Ryan SP.

J Orthop Trauma. 2017 Nov;31(11):e375-e380. doi: 10.1097/BOT.0000000000000954.

PMID:
28827510
10.

On Suggestibility and Placebo: A Follow-Up Study.

Lifshitz M, Sheiner EO, Olson JA, Thériault R, Raz A.

Am J Clin Hypn. 2017 Apr;59(4):385-392. doi: 10.1080/00029157.2016.1225252.

PMID:
28300519
11.

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.

Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM.

J Clin Oncol. 2016 Sep 20;34(27):3308-14. doi: 10.1200/JCO.2015.65.8013. Epub 2016 Aug 1.

PMID:
27480155
12.

National Trends in Primary Total Hip Arthroplasty in Extremely Young Patients: A Focus on Bearing Surface Usage From 2009 to 2012.

Rajaee SS, Theriault RV, Pevear ME, Smith EL.

J Arthroplasty. 2016 Sep;31(9 Suppl):63-8. doi: 10.1016/j.arth.2016.01.061. Epub 2016 Apr 2.

PMID:
27430185
13.

Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.

Halasz LM, Uno H, Hughes M, D'Amico T, Dexter EU, Edge SB, Hayman JA, Niland JC, Otterson GA, Pisters KM, Theriault R, Weeks JC, Punglia RS.

Cancer. 2016 Jul 1;122(13):2091-100. doi: 10.1002/cncr.30009. Epub 2016 Apr 18.

14.

Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.

Vaz-Luis I, Hughes ME, Cronin A, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU.

Breast Cancer Res Treat. 2016 Feb;155(3):569-78. doi: 10.1007/s10549-016-3707-1. Epub 2016 Feb 11.

PMID:
26868124
15.

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.

Mougalian SS, Hernandez M, Lei X, Lynch S, Kuerer HM, Symmans WF, Theriault RL, Fornage BD, Hsu L, Buchholz TA, Sahin AA, Hunt KK, Yang WT, Hortobagyi GN, Valero V.

JAMA Oncol. 2016 Apr;2(4):508-16. doi: 10.1001/jamaoncol.2015.4935.

16.

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.

Tseng YD, Uno H, Hughes ME, Niland JC, Wong YN, Theriault R, Blitzblau RC, Moy B, Breslin T, Edge SB, Hassett MJ, Punglia RS.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):622-30. doi: 10.1016/j.ijrobp.2015.07.006. Epub 2015 Jul 11.

PMID:
26461004
17.

Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy.

He H, Cai C, Charnsangavej C, Theriault RL, Green M, Quraishi MA, Yang WT.

Can Assoc Radiol J. 2015 Nov;66(4):356-62. doi: 10.1016/j.carj.2015.03.005. Epub 2015 Jul 10.

18.

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.

J Clin Oncol. 2015 Jul 10;33(20):2254-61. doi: 10.1200/JCO.2014.57.1349. Epub 2015 May 11.

19.

Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer.

Kogawa T, Fouad TM, Wei C, Masuda H, Kai K, Fujii T, El-Zein R, Chavez-MacGregor M, Litton JK, Brewster A, Alvarez RH, Hortobagyi GN, Valero V, Theriault R, Ueno NT.

J Cancer. 2015 Jan 22;6(4):310-8. doi: 10.7150/jca.10580. eCollection 2015.

20.

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.

Vaz-Luis I, Hughes ME, Cronin AM, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU.

Cancer. 2015 Jun 15;121(12):1937-48. doi: 10.1002/cncr.29310. Epub 2015 Mar 10.

21.

Outcomes of children exposed in utero to chemotherapy for breast cancer.

Murthy RK, Theriault RL, Barnett CM, Hodge S, Ramirez MM, Milbourne A, Rimes SA, Hortobagyi GN, Valero V, Litton JK.

Breast Cancer Res. 2014 Dec 30;16(6):500. doi: 10.1186/s13058-014-0500-0.

22.

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.

Wolff AC, Blackford AL, Visvanathan K, Rugo HS, Moy B, Goldstein LJ, Stockerl-Goldstein K, Neumayer L, Langbaum TS, Theriault RL, Hughes ME, Weeks JC, Karp JE.

J Clin Oncol. 2015 Feb 1;33(4):340-8. doi: 10.1200/JCO.2013.54.6119. Epub 2014 Dec 22. Erratum in: J Clin Oncol. 2015 Apr 1;33(10):1227.

23.

Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.

Kai M, Kogawa T, Liu DD, Fouad TM, Kai K, Niikura N, Hsu L, Willey JS, Theriault RL, Valero V, Ueno NT.

Clin Breast Cancer. 2015 Feb;15(1):37-42. doi: 10.1016/j.clbc.2014.06.007. Epub 2014 Aug 15.

PMID:
25258308
24.

Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.

Woodson AH, Muse KI, Lin H, Jackson M, Mattair DN, Schover L, Woodard T, McKenzie L, Theriault RL, Hortobágyi GN, Arun B, Peterson SK, Profato J, Litton JK.

Oncologist. 2014 Aug;19(8):797-804. doi: 10.1634/theoncologist.2014-0057. Epub 2014 Jun 20.

25.

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.

Vaz-Luis I, Ottesen RA, Hughes ME, Mamet R, Burstein HJ, Edge SB, Gonzalez-Angulo AM, Moy B, Rugo HS, Theriault RL, Weeks JC, Winer EP, Lin NU.

J Clin Oncol. 2014 Jul 10;32(20):2142-50. doi: 10.1200/JCO.2013.53.1608. Epub 2014 Jun 2.

26.

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.

Abdayem P, Ghosn M, Valero V, Walters R, Arun B, Murray JL, Theriault R, Frye D, Ibrahim NK.

J Cancer. 2014 Mar 29;5(5):351-9. doi: 10.7150/jca.8304. eCollection 2014.

27.

Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.

Gagliato Dde M, Gonzalez-Angulo AM, Lei X, Theriault RL, Giordano SH, Valero V, Hortobagyi GN, Chavez-Macgregor M.

J Clin Oncol. 2014 Mar 10;32(8):735-44. doi: 10.1200/JCO.2013.49.7693. Epub 2014 Jan 27.

28.

Reply to D. Crivellari et al.

Theriault RL, Litton JK.

J Clin Oncol. 2014 Jan 20;32(3):256-7. doi: 10.1200/JCO.2013.53.1020. Epub 2013 Dec 2. No abstract available.

PMID:
24297948
29.

Ethnic disparities in adherence to breast cancer survivorship surveillance care.

Advani PS, Ying J, Theriault R, Melhem-Bertrand A, Moulder S, Bedrosian I, Tereffe W, Black S, Pini TM, Brewster AM.

Cancer. 2014 Mar 15;120(6):894-900. doi: 10.1002/cncr.28490. Epub 2013 Nov 20.

30.

The safety of chemotherapy for breast cancer patients with hepatitis C virus infection.

Miura Y, Theriault RL, Naito Y, Suyama K, Shimomura A, Iwatani T, Miura D, Kawabata H, Kumada H, Takano T.

J Cancer. 2013 Jul 24;4(6):519-23. doi: 10.7150/jca.6231. Print 2013.

31.

Breast cancer, version 3.2013: featured updates to the NCCN guidelines.

Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar R; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Jul;11(7):753-60; quiz 761.

32.

Pregnancy during or after breast cancer diagnosis: what do we know and what do we need to know?

Theriault RL, Litton JK.

J Clin Oncol. 2013 Jul 10;31(20):2521-2. doi: 10.1200/JCO.2013.49.7347. Epub 2013 Jun 3. No abstract available.

PMID:
23733755
33.

Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer.

Litton JK, Warneke CL, Hahn KM, Palla SL, Kuerer HM, Perkins GH, Mittendorf EA, Barnett C, Gonzalez-Angulo AM, Hortobágyi GN, Theriault RL.

Oncologist. 2013;18(4):369-76. doi: 10.1634/theoncologist.2012-0340. Epub 2013 Apr 10.

34.

Leakage associated with urinary catheter usage: a design challenge.

Theriault R, Ward-Smith P, Soper C.

Urol Nurs. 2012 Nov-Dec;32(6):307-12.

PMID:
23362699
35.

Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.

Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis CA, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC.

J Natl Cancer Inst. 2013 Jan 16;105(2):104-12. doi: 10.1093/jnci/djs506. Epub 2012 Dec 21.

36.

Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program.

Blinder VS, Norris VW, Peacock NW, Griggs JJ, Harrington DP, Moore A, Theriault RL, Partridge AH; American Society of Clinical Oncology Breast Cancer Registry Pilot Steering Group.

Cancer. 2013 Jan 1;119(1):164-72. doi: 10.1002/cncr.27856. Epub 2012 Nov 29.

37.

Time to diagnosis and breast cancer stage by race/ethnicity.

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.

Breast Cancer Res Treat. 2012 Dec;136(3):813-21. doi: 10.1007/s10549-012-2304-1. Epub 2012 Oct 26.

38.

A prospective study of bone tumor response assessment in metastatic breast cancer.

Hayashi N, Costelloe CM, Hamaoka T, Wei C, Niikura N, Theriault RL, Hortobagyi GN, Madewell JE, Ueno NT.

Clin Breast Cancer. 2013 Feb;13(1):24-30. doi: 10.1016/j.clbc.2012.09.004. Epub 2012 Oct 24.

39.

Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.

Vaz-Luis I, Ottesen RA, Hughes ME, Marcom PK, Moy B, Rugo HS, Theriault RL, Wilson J, Niland JC, Weeks JC, Lin NU.

Breast Cancer Res. 2012 Oct 1;14(5):R129. doi: 10.1186/bcr3324.

40.

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.

Freedman RA, Hughes ME, Ottesen RA, Weeks JC, He Y, Wong YN, Theriault R, Keating NL.

Cancer. 2013 Feb 15;119(4):839-46. doi: 10.1002/cncr.27831. Epub 2012 Sep 25.

41.

Global rating scale for the assessment of paramedic clinical competence.

Tavares W, Boet S, Theriault R, Mallette T, Eva KW.

Prehosp Emerg Care. 2013 Jan-Mar;17(1):57-67. doi: 10.3109/10903127.2012.702194. Epub 2012 Jul 26.

PMID:
22834959
42.

Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Soliman H, Somlo G, Theriault RL, Ward JH, Wolff AC, Zellars R, Kumar R, Shead DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Jul 1;10(7):821-9.

43.

Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.

Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ.

Cancer. 2012 Dec 15;118(24):6022-30. doi: 10.1002/cncr.27691. Epub 2012 Jun 6.

44.

Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.

Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC.

J Clin Oncol. 2012 Jun 20;30(18):2218-26. doi: 10.1200/JCO.2011.38.5740. Epub 2012 May 14.

45.

The effect of age on delay in diagnosis and stage of breast cancer.

Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM.

Oncologist. 2012;17(6):775-82. doi: 10.1634/theoncologist.2011-0469. Epub 2012 May 3.

46.

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.

Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, Blayney DW, Niland JC, Winer EP, Weeks JC.

Cancer. 2012 Nov 15;118(22):5463-72. doi: 10.1002/cncr.27581. Epub 2012 Apr 27.

47.

Biology of bone metastases.

Theriault RL, Theriault RL.

Cancer Control. 2012 Apr;19(2):92-101. Review.

PMID:
22487971
48.

Health care costs: how do we decide value? When do we decide? How do we particularize the decisions?

Theriault RL.

Oncologist. 2012;17(2):157-9. doi: 10.1634/theoncologist.2011-0371. Epub 2012 Feb 2. No abstract available.

49.

Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.

Niikura N, Liu J, Hayashi N, Palla SL, Tokuda Y, Hortobagyi GN, Ueno NT, Theriault RL.

Cancer. 2012 Apr 15;118(8):2039-47. doi: 10.1002/cncr.26512. Epub 2011 Dec 2.

50.

Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.

Arun BK, Dhinghra K, Valero V, Kau SW, Broglio K, Booser D, Guerra L, Yin G, Walters R, Sahin A, Ibrahim N, Buzdar AU, Frye D, Sneige N, Strom E, Ross M, Theriault RL, Vadhan-Raj S, Hortobagyi GN.

Oncologist. 2011;16(11):1527-34. doi: 10.1634/theoncologist.2011-0134. Epub 2011 Oct 31.

Supplemental Content

Loading ...
Support Center